New Mode of Insulin Delivery

A new way to treat diabetes may be just around the corner. Several biotechnology companies are in hot pursuit of an oral form of insulin. So far, two options exits for patients with diabetes who require insulin – pumps or syringes, with other needle-free options remaining elusive. In 2007, Pfizer, Inc., withdrew Exubera, an inhaled […]